Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-048711
Filing Date
2008-03-06
Accepted
2008-03-06 13:51:33
Documents
6
Period of Report
2007-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 857065
2 LIST OF SUBSIDIARIES dex21.htm EX-21 1502
3 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex23.htm EX-23 1971
4 CERTIFICATION OF THE CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9345
5 CERTIFICATION OF THE CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9324
6 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 1350 dex32.htm EX-32 4389
  Complete submission text file 0001193125-08-048711.txt   884997
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Filer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0101
Type: 10-K | Act: 34 | File No.: 000-21794 | Film No.: 08670411
SIC: 2836 Biological Products, (No Diagnostic Substances)